Hyperuricemia as a predictor and screening tool for preeclampsia

Authors

DOI:

https://doi.org/10.56294/saludcyt2022220

Keywords:

Uric Acid, Diagnosis, Pregnancy, Hyperuricemia, Preeclampsia

Abstract

Introduction: preeclampsia is a hypertensive condition that negatively affects the pregnant woman and fetus, producing complications such as morbidity and mortality. Uric acid plays a role in the development of preeclampsia, although there is still no solid evidence to support this theory. This parameter is an additional tool in the screening for preeclampsia, which allows health personnel to identify and treat this complication early.
Objective: describe hyperuricemia as a predictor and screening tool for preeclampsia.
Methods: a review was carried out in different databases such as PubMed, Scopus and LILACS. After searching and filtering the results obtained, 8 articles were selected and analyzed accordingly.
Result: the elevation of serum uric acid concentration preceded by a hypertensive state in pregnant women, especially during the first trimester, especially in complicated pregnancies and with a high risk of developing preeclampsia. In addition, it has been suggested that the measurement of this and other biomarkers that contribute to oxidative stress may help in the control and early treatment of the disease.
Conclusion: hyperuricemia can be useful as a predictor and screening tool for preeclampsia, allowing to determine the severity of the pathology and the appearance of complications

References

1. Haas S de, Mulder E, Schartmann N, Mohseni Z, Hasson FA, Alsadah F, et al. Blood pressure ad-justments throughout healthy and hypertensive pregnancy: A systematic review and meta-analysis. Pregnancy Hypertension 2022;27:51-8. https://doi.org/10.1016/J.PREGHY.2021.12.004.

2. Kozlowski S, Zgliczynska M, Kosinska-Kaczynska K. Biomarkers of angiogenesis in twin gestations and the risk of preeclampsia - review of the current literature. Ginekologia polska 2020;91:773-6. https://doi.org/10.5603/GP.A2020.0133.

3. Ryu A, Cho NJ, Kim YS, Lee EY. Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia. Medicine 2019;98:e15462. https://doi.org/10.1097/MD.0000000000015462.

4. MacDonald TM, Walker SP, Hannan NJ, Tong S, Kaitu’u-Lino TJ. Clinical tools and biomarkers to predict preeclampsia. EBioMedicine 2022;75:103780. https://doi.org/10.1016/J.EBIOM.2021.103780.

5. Bone JN, Magee LA, Singer J, Nathan H, Qureshi RN, Sacoor C, et al. Blood pressure thresholds in pregnancy for identifying maternal and infant risk: a secondary analysis of Community-Level In-terventions for Pre-eclampsia (CLIP) trial data. The Lancet Global Health 2021;9:e1119-28. https://doi.org/10.1016/S2214-109X(21)00219-9.

6. Poon LC, Magee LA, Verlohren S, Shennan A, Dadelszen P von, Sheiner E, et al. A literature re-view and best practice advice for second and third trimester risk stratification, monitoring, and management of pre- eclampsia. Int J Gynecol Obstet 2021;154:3-31. https://doi.org/10.1002/ijgo.13763.

7. Antwi E, Amoakoh-Coleman M, Vieira DL, Madhavaram S, Koram KA, Grobbee DE, et al. System-atic review of prediction models for gestational hypertension and preeclampsia. PLoS ONE 2020;15. https://doi.org/10.1371/JOURNAL.PONE.0230955.

8. Lee K, Brayboy · Lynae, Tripathi A. Pre-eclampsia: a Scoping Review of Risk Factors and Sugges-tions for Future Research Direction. Regen Eng Transl Med 2022;10:1-13. https://doi.org/10.1007/s40883-021-00243-w.

9. Moreira-Flores MIM, Montes-Vélez RIS. Incidence and severity of preeclampsia in Ecuador Incidên-cia e gravidade da pré-eclâmpsia no Equador. núm 1 Enero-marzo 2022;8:876-84. https://doi.org/10.23857/dc.v8i41.2528.

10. Johnson RJ, Sanchez-Lozada LG, Rodriguez-Iturbe B, Kelley EE, Nakagawa T, Madero M, et al. Uric Acid and Hypertension: An Update With Recommendations. American Journal of Hyperten-sion 2020;33:583. https://doi.org/10.1093/ajh/hpaa044.

11. Álvarez Ponce VA, Rodríguez Baquero M, Pardo Mederos JM, Rodríguez Llobera A. El ácido úrico como factor predictor de la preeclampsia. Revista Cubana de Obstetricia y Ginecología 2018;44:1-9.

12. Stewart DJ, Langlois V, Noone D. Hyperuricemia and Hypertension: Links and Risks. Integrated Blood Pressure Control 2019;12:43. https://doi.org/10.2147/IBPC.S184685.

13. Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population‐based study. BMC Pregnancy and Childbirth 2021;21. https://doi.org/10.1186/s12884-021-03809-2.

14. Ortved D, Hawkins L-A, Johnson J-A, Hyett J, Metcalfe A. Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia. Ultrasound Obstet Gynecol 2019;53:239-44. https://doi.org/10.1002/uog.19076.

15. Cedeño MF, Cedeño MF, Llanes OMA, Morales MM. Ácido úrico en las gestantes con diagnóstico de drepanocitosis y preeclampsia. Revista Cubana de Hematología, Inmunología y Hemoterapia 2022;38.

16. Aouache R, Biquard L, Vaiman D, Miralles F. Molecular Sciences Oxidative Stress in Preeclampsia and Placental Diseases 2018;19:1496. https://doi.org/10.3390/ijms19051496.

17. Zakiyah N, Tuytten R, Baker PN, Kenny LC, Postma MJ, Asselt ADI van. Early cost-effectiveness analysis of screening for preeclampsia in nulliparous women: A modelling approach in European high-income settings. PLoS ONE 2022;17. https://doi.org/10.1371/JOURNAL.PONE.0267313.

18. Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Trisha AD, et al. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Scientific Reports | 2021;11:21339. https://doi.org/10.1038/s41598-021-00839-w.

19. Bellos I, Pergialiotis V, Loutradis D, Daskalakis G. The prognostic role of serum uric acid levels in preeclampsia: A meta-analysis. Journal of clinical hypertension (Greenwich, Conn) 2020;22:826-34. https://doi.org/10.1111/JCH.13865.

20. Yescas I, Razo R, Ávila J, Cejudo J, Elizalde V, Herrera J, et al. Correlación de la concentra-ción sérica de ácido úrico en pacientes con preeclampsia severa en la unidad de cuidados inten-sivos. Ginecol Obstet Mex 2017;85:347-54.

21. Omertayeva D, Ponamaryova O, Amirbekova Z, Vazenmiller D, Mugazov M. Diagnostic value of determining the level of purine metabolism intermediates in pregnant women with chronic hy-pertension and superimposed preeclampsia. Journal of Nephropathology 2021;10. https://doi.org/10.34172/JNP.2021.25.

22. Medjedovic E, Kurjak A. The Importance of Doppler Analysis of Uterine Circulation in Pregnancy for a Better Understanding of Preeclampsia. Medical archives (Sarajevo, Bosnia and Herze-govina) 2021;75:424-30. https://doi.org/10.5455/MEDARH.2021.75.424-430.

23. Afrose D, Chen H, Ranashinghe A, Liu C chi, Henessy A, Hansbro PM, et al. The diagnostic po-tential of oxidative stress biomarkers for preeclampsia: systematic review and meta-analysis. Bi-ology of sex differences 2022;13. https://doi.org/10.1186/S13293-022-00436-0.

24. Vadell HC, Nip ML, Diéguez AC, Barroso RL, Guerra EDÁ. El análisis multivariado a partir del estado redox asociado a la preeclampsia. Rev cuba obstet ginecol 2017:107-18.

25. Preethi DS, Rai L, Nambiar J, Kumar P, Pai MV, Amin SV. Role of Laboratory Investigations to Assess Maternal and Perinatal Outcome in Hypertensive Mothers. International Journal of Infer-tility and Fetal Medicine 2017;8:18-23. https://doi.org/10.5005/jp-journals-10016-1142.

26. Pasyar S, Wilson LM, Pudwell J, Peng YP, Smith GN. Investigating the diagnostic capacity of uric acid in the occurrence of preeclampsia. Pregnancy Hypertension 2020;19:106-11. https://doi.org/10.1016/j.preghy.2019.12.010.

27. Shakarami A, Ghafarzadeh M, Yari F, Fathi L. Association between maternal serum uric acid and preeclampsia. Archives of Physiology and Biochemistry 2020:1-4. https://doi.org/10.1080/13813455.2020.1773863.

28. Corominas AI, Medina Y, Balconi S, Casale R, Farina M, Martínez N, et al. Assessing the Role of Uric Acid as a Predictor of Preeclampsia. Front Physiol 2022;12:785219. https://doi.org/10.3389/fphys.2021.785219.

29. Hassen FS, Malik T, Dejenie TA. Evaluation of serum uric acid and liver function tests among pregnant women with and without preeclampsia at the University of Gondar Comprehensive Spe-cialized Hospital, Northwest Ethiopia. PLOS ONE 2022;17:e0272165. https://doi.org/10.1371/journal.pone.0272165.

Downloads

Published

2022-12-31

How to Cite

1.
Tenemaza Ortega KV, Cárdenas Heredia FR, Sánchez Peralta SM, Ordoñez Vázquez MJ. Hyperuricemia as a predictor and screening tool for preeclampsia. Salud, Ciencia y Tecnología [Internet]. 2022 Dec. 31 [cited 2025 Apr. 24];2:220. Available from: https://sct.ageditor.ar/index.php/sct/article/view/63